Susquehanna International Group
GRI

Susquehanna International Group’s GRI Bio GRI Stock Holding History

Susquehanna International Group’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-68
Closed -$11.7K – 12593
2024
Q3 		$11.7K Buy
+68
New +$27.4K ﹤0.01% 11706
2023
Q2 		– Hold
0
– -$5.46K – 12480
2023
Q1 		– Hold
0
– – – 12296
2022
Q4 		– Hold
0
– -$14K – 12892
2022
Q3 		– Hold
0
– – – 12717
2022
Q2 		– Hold
0
– – – 12327

Other funds holding GRI

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group's GRI Position: Q4 2024 in Review

Susquehanna International Group sold out of GRI Bio (GRI) in Q4 2024, closing a stake of 68 shares — an estimated $11.7K sold.

Susquehanna International Group first reported a position in GRI in Q3 2024 and held it in 1 quarter. The position peaked at $11.7K in Q3 2024. 7 funds tracked by Wall St. Rank hold GRI as of Q4 2024.

  • Susquehanna International Group reported no remaining GRI Bio position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 68 GRI Bio shares in Q4 2024, an estimated $11.7K.
  • Susquehanna International Group first reported a position in GRI Bio in Q3 2024 and held it in 1 quarter.
  • Susquehanna International Group's GRI Bio position peaked at $11.7K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held GRI Bio as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.